Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$667K Sell
3,226
-20
-0.6% -$4.44K 0.25% 65
2025
Q4
$724K Buy
3,246
+862
+36% +$196K 0.27% 66
2025
Q3
$537K Buy
2,384
+128
+6% +$26.1K 0.23% 74
2025
Q2
$445K Buy
2,256
+313
+16% +$58.2K 0.21% 81
2025
Q1
$376K Buy
+1,943
New +$378K 0.19% 82
2023
Q1
Sell
-2,496
Closed -$403K 86
2022
Q4
$403K Sell
2,496
-7
-0.3% -$1.07K 0.28% 55
2022
Q3
$336K Buy
2,503
+857
+52% +$123K 0.25% 56
2022
Q2
$252K Buy
+1,646
New +$252K 0.22% 72

Other funds holding ABBV

FWG Holdings's ABBV Position: Q1 2026 in Review

FWG Holdings reduced its AbbVie (ABBV) stake by 0.62% in Q1 2026, selling an estimated $4.44K and leaving 3,226 shares worth $667K. The position accounts for 0.25% of the portfolio, ranked #65.

FWG Holdings first reported a position in ABBV in Q2 2022 and has held it in 8 quarters since. The position peaked at $724K in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • FWG Holdings held 3,226 shares of AbbVie worth $667K as of Q1 2026.
  • FWG Holdings sold 20 AbbVie shares in Q1 2026, an estimated $4.44K.
  • AbbVie made up 0.25% of FWG Holdings's portfolio in Q1 2026, its #65 holding.
  • FWG Holdings first reported a position in AbbVie in Q2 2022 and has held it in 8 quarters since.
  • FWG Holdings's AbbVie position peaked at $724K in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on FWG Holdings's 13F filing for Q1 2026, filed 13 Apr 2026.